logo

Merck Kgaa (MKGAY.PK)



Trade MKGAY.PK now with
  Date
  Headline
12/10/2018 10:02:00 AM Merck KGaA Announces FDA Orphan Drug Designation For Bifunctional Immunotherapy M7824 In Biliary Tract Cancer
12/6/2018 8:09:20 AM Merck KGaA Enters Licensing Agreement With Cyclica Inc. For Use Of Ligand Express
11/19/2018 7:15:50 AM Merck KGaA And Pfizer Announce That Phase III JAVELIN Ovarian 200 Trial Did Not Meet Prespecified Primary Endpoints
11/14/2018 1:02:02 AM Merck KGaA Q3 Group Sales Up 6.6% To EUR 3.7 Bln
11/12/2018 4:12:17 AM Merck KGaA Signs Deal With Guangzhou Development District On Innovation Development
10/16/2018 1:31:49 AM Merck KGaA Expects Strong Growth Impetus Starting Next Year
10/10/2018 2:12:31 AM Merck KGaA Announces Presentation Of New Data For Cladribine Tablet
10/9/2018 2:13:56 AM Merck KGaA Announces First Presentation Of Phase III Data For Avelumab In Previously Untreated, Advanced Kidney Cancer
10/8/2018 6:04:38 AM Merck KGaA To Present Data On MS Portfolio At ECTRIMS 2018
9/24/2018 8:15:06 AM Immutep Enters Into Clinical Trial Collaboration And Supply Agreement With Merck KGaA And Pfizer
9/11/2018 8:30:45 AM Merck KGaA, Pfizer Report Positive Top-line Results From Pivotal Phase III JAVELIN Renal 101 Study